Cover Image
市場調查報告書

全球伊波拉感染分析

Global Analysis of Ebola Disease

出版商 Frost & Sullivan 商品編碼 319488
出版日期 內容資訊 英文 37 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
全球伊波拉感染分析 Global Analysis of Ebola Disease
出版日期: 2014年11月18日 內容資訊: 英文 37 Pages
簡介

本報告提供全球伊波拉感染(伊波拉病毒感染)調查分析、伊波拉病毒的患者數相關資料、至2016年的市場規模與收益預測,也包含競爭情形等,有系統的資訊。

本調查涵蓋內容

  • 伊波拉的診斷市場預測為何?
  • 伊波拉的新病例的預測與相關的負擔為何?
  • 診斷用產品和開發平台的藥物/疫苗為何?
  • 伊波拉蔓延造成的潛在性全球支出為何?

第1章 摘要整理

第2章 市場概要

  • 伊波拉是什麼?
  • 主要事件的時間序列
  • 調查範圍與區分
  • 調查內容
  • CEO預測
  • 伊波拉的蔓延
  • 調查手法、前提條件、定義
  • 伊波拉的患者數預測(全球)
  • 伊波拉的分子檢驗市場(全球)
  • 伊波拉的免疫診斷檢驗市場(全球)
  • 全球支出預測:伊波拉輕症
  • 全球支出預測:伊波拉重症
  • 全球支出預測:伊波拉輕症和重症比較

第3章 競爭情形

  • 開發平台疫苗及藥物的競爭情形
  • 診斷用產品的競爭情形

第4章 值得注意的企業

  • 伊波拉診斷
  • 伊波拉藥物和疫苗
  • 免責聲明

第5章 關於FROST & SULLIVAN

目錄
Product Code: NED3-01-00-00-00

Expenditure on Prevention and Containment to Soar towards $5.9 Billion by End of 2016

This market insight provides a first-of-its-kind analysis of market sizing and revenue forecasts through 2016 for the prevalent Ebola virus. The number of people infected nears 10,000 globally, and the Centers for Disease Control and Prevention (CDC) and World Health Organization (WHO) have deemed this the worst outbreak due to the death toll nearing 5,000. The Ebola market is segmented by diagnostics and pharmaceuticals, and the diagnostics market includes both molecular methods and immunodiagnostics tests, of which a 2-year potential-revenue forecast is provided. Molecular methods will see wide adoption for the specificity, sensitivity, and rapidity of the tests. Competitive landscape and companies to watch chapters are provided.

Key Questions This Study Will Answer

  • What is the outlook for the Ebola diagnostics market ?
  • What are the key predictions for new Ebola cases and the associated burden in 2015 and 2016?
  • What are some of the diagnostic products and drug/vaccines in the pipeline to help contain this disease?
  • What is the potential global expenditure due to the prevalence of Ebola?

Table of Contents

1. EXECUTIVE SUMMARY

Executive Summary

  • 1. Key Findings

2. MARKET OVERVIEW

Market Overview

  • 1. What is Ebola?
  • 2. Timeline of Key Events
  • 3. Scope and Segmentation
  • 4. Key Questions This Study Will Answer
  • 5. CEO's Perspective
  • 6. Spread of Ebola
  • 7. Methodology, Assumptions, and Definitions
  • 8. Methodology, Assumptions, and Definitions (continued)
  • 9. Methodology, Assumptions, and Definitions (continued)
  • 10. Methodology, Assumptions, and Definitions (continued)
  • 11. Projected Ebola Prevalence (Global)
  • 12. Ebola Market for Molecular Tests (Global)
  • 13. Ebola Market for Immunodiagnostic Tests (Global)
  • 14. Global Expenditure Forecast by Mild Cases of Ebola
  • 15. Global Expenditure Forecast by Severe Cases of Ebola
  • 16. Global Expenditure Forecast Comparing Mild and Severe Ebola Cases

3. COMPETITIVE LANDSCAPE

Competitive Landscape

  • 1. Competitive Landscape for Pipeline Vaccines and Drugs
  • 2. Competitive Landscape for Diagnostic Products

4. COMPANIES TO WATCH

Companies to Watch

  • 1. Ebola Diagnostics
  • 2. Ebola Drugs and Vaccines
  • 3. Legal Disclaimer

5. THE FROST & SULLIVAN STORY

The Frost & Sullivan Story

  • 1. The Frost & Sullivan Story
  • 2. Value Proposition-Future of Your Company & Career
  • 3. Global Perspective
  • 4. Industry Convergence
  • 5. 360° Research Perspective
  • 6. Implementation Excellence
  • 7. Our Blue Ocean Strategy
Back to Top